Clinical Trials Directory

Trials / Conditions / Superficial Bladder Cancer

Superficial Bladder Cancer

17 registered clinical trials studyying Superficial Bladder Cancer — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingLEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BC
NCT04752722
enGene, Inc.Phase 1 / Phase 2
UnknownComparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation
NCT05084586
Ankara Training and Research HospitalN/A
RecruitingPhase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer
NCT03379909
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Phase 2
UnknownA New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
NCT03121768
Mansoura University—
CompletedADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle
NCT02773849
Ferring PharmaceuticalsPhase 3
CompletedEvaluation of a Patient-Reported Symptom Index for NMIBC
NCT03091764
University of Sydney—
Active Not RecruitingTherapeutic Instillation of Mistletoe
NCT02106572
Abnoba GmbhPhase 3
CompletedIntravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer
NCT01687244
FKD Therapies OyPhase 2
CompletedIntravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract Symptoms
NCT01939756
Savino M. Di StasiPhase 1 / Phase 2
CompletedStudy of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladde
NCT00782587
Halozyme TherapeuticsPhase 1
CompletedMitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer
NCT00734994
Mark DewhirstEARLY_Phase 1
CompletedPhase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer
NCT00595088
Anchiano Therapeutics Israel Ltd.Phase 2
CompletedSequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer
NCT00322699
North Florida/South Georgia Veterans Health SystemPhase 1 / Phase 2
CompletedIntravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With S
NCT00191711
Eli Lilly and CompanyPhase 2
CompletedMaximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Ca
NCT02007005
Abnoba GmbhPhase 1 / Phase 2
CompletedA Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With
NCT00192049
Eli Lilly and CompanyPhase 2
CompletedPreoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer
NCT01149174
University of Rome Tor VergataPhase 3